| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | 40 kDa proline rich AKT substrate ; 40 kDa proline-rich AKT substrate; AKT1 S1; AKT1 substrate 1 (proline rich) ; AKT1 substrate 1; AKT1S 1; AKT1S1; AKTS1_HUMAN; Lobe; MGC2865; PRAS 40; PRAS; PRAS40; Proline rich akt substrate ; Proline rich Akt substrate 40 kDa; Proline-rich AKT1 substrate 1 |
| Antigen | |
| Clonality | |
| Conjugate | |
| Form | Liquid |
| Host | |
| Immunogen | Synthesized peptide derived from Human PRAS40 around the non-phosphorylation site of T246. |
| Isotype | |
| Product Type | |
| Reactivity | |
| Source | This product is a polyclonal antibody purified from rabbit antiserum. |
| Storage | |
| Target | |
| UniProt # |
Product Overview
Primary AntibodyThis antibody targets AKT1S1 and was raised against a recombinant protein immunogen.
Validated Applications
| Application | Recommended Dilution |
|---|---|
| Western Blot (WB) | WB:1:500-1:2000, IHC:1:100-1:300, ELISA:1:5000 |
| Immunohistochemistry (IHC) | WB:1:500-1:2000, IHC:1:100-1:300, ELISA:1:5000 |
| ELISA | WB:1:500-1:2000, IHC:1:100-1:300, ELISA:1:5000 |
Antibody Specifications
| Target | AKT1S1 |
|---|---|
| Host | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Conjugate | Unconjugated |
| Reactivity | Human, Mouse, Rat |
| Purification | Affinity Purification |
| Antigen / Immunogen | Synthesized peptide derived from Human PRAS40 around the non-phosphorylation site of T246. |
| Production | This product is a polyclonal antibody purified from rabbit antiserum. |
| Form | Liquid |
| Storage Buffer | PBS, 50% glycerol, 0.5% BSA, 0.02% sodium azide, pH 7.4. |
| Storage | Upon receipt, store at -20°C or -80°C. Avoid repeated freeze. |
Alternative Names
40 kDa proline rich AKT substrate ; 40 kDa proline-rich AKT substrate; AKT1 S1; AKT1 substrate 1 (proline rich) ; AKT1 substrate 1; AKT1S 1; AKT1S1; AKTS1_HUMAN; Lobe; MGC2865; PRAS 40; PRAS; PRAS40; Proline rich akt substrate ; Proline rich Akt substrate 40 kDa; Proline-rich AKT1 substrate 1
Safety & Handling
| Target | AKT1S1 |
| Host | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Conjugate | Unconjugated |
| Reactivity | Human, Mouse, Rat |
| Purification | Affinity Purification |
| Antigen/Immunogen | Synthesized peptide derived from Human PRAS40 around the non-phosphorylation site of T246. |
| Production | This product is a polyclonal antibody purified from rabbit antiserum. |
| Form | Liquid |
| Storage Buffer | PBS, 50% glycerol, 0.5% BSA, 0.02% sodium azide, pH 7.4. |
| Storage | Upon receipt, store at -20°C or -80°C. Avoid repeated freeze. |
Dilutions are starting recommendations. Titration is advised for each system.
| Application | Recommended Dilution |
|---|---|
| Western Blot (WB) | WB:1:500-1:2000, IHC:1:100-1:300, ELISA:1:5000 |
| Immunohistochemistry (IHC) | WB:1:500-1:2000, IHC:1:100-1:300, ELISA:1:5000 |
| ELISA | WB:1:500-1:2000, IHC:1:100-1:300, ELISA:1:5000 |
Immunogen: Synthesized peptide derived from Human PRAS40 around the non-phosphorylation site of T246.
Antigen Species: Human
Alternative Names
40 kDa proline rich AKT substrate ; 40 kDa proline-rich AKT substrate; AKT1 S1; AKT1 substrate 1 (proline rich) ; AKT1 substrate 1; AKT1S 1; AKT1S1; AKTS1_HUMAN; Lobe; MGC2865; PRAS 40; PRAS; PRAS40; Proline rich akt substrate ; Proline rich Akt substrate 40 kDa; Proline-rich AKT1 substrate 1
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
